Search

everythinglearnresearchcommunity

for

Search:↓

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

wAMD patients have higher oxidative stress, suggesting antioxidant treatment may help.

Women with irregular periods have a higher risk of heart disease.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Alopecia patients have less GPER-1, which might affect hair loss.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Higher aldosterone levels link to hair loss and high blood pressure.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

People with more knowledge about their hair loss condition and those who see it as a serious issue are more likely to seek treatment.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Survivors of severe COVID-19 need ongoing care to manage lasting health issues.

Fungal infections are the most common skin issue in the region.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Patients with acne vulgaris have lower serum irisin levels.

Post-bariatric surgery patients often face gastrointestinal issues, fatigue, dry skin, hair loss, and anxiety.

Patients with pernio have lower vitamin B12 and ferritin levels than healthy people.